China's reform of the regulatory system for medical products and its impact | |
Song, Ruilin1,2; Sang, Guowei2; Geng, Meiyu3; Jiang, Hualiang3 | |
刊名 | NATIONAL SCIENCE REVIEW |
2019 | |
卷号 | 6期号:1页码:1-1 |
ISSN号 | 2095-5138 |
DOI | 10.1093/nsr/nwz001 |
通讯作者 | Jiang, Hualiang(hljiang@simm.ac.cn) |
WOS研究方向 | Science & Technology - Other Topics |
语种 | 英语 |
出版者 | OXFORD UNIV PRESS |
WOS记录号 | WOS:000462696500001 |
内容类型 | 期刊论文 |
源URL | [http://119.78.100.183/handle/2S10ELR8/290161] |
专题 | 中国科学院上海药物研究所 |
通讯作者 | Jiang, Hualiang |
作者单位 | 1.China Pharmaceut Innovat & Res Dev Assoc, Beijing, Peoples R China 2.China Pharmaceut Univ, Res Ctr Natl Drug Policy & Ecosyst, Nanjing, Jiangsu, Peoples R China 3.Chinese Acad Sci, Shanghai Inst Mat Med, Beijing, Peoples R China |
推荐引用方式 GB/T 7714 | Song, Ruilin,Sang, Guowei,Geng, Meiyu,et al. China's reform of the regulatory system for medical products and its impact[J]. NATIONAL SCIENCE REVIEW,2019,6(1):1-1. |
APA | Song, Ruilin,Sang, Guowei,Geng, Meiyu,&Jiang, Hualiang.(2019).China's reform of the regulatory system for medical products and its impact.NATIONAL SCIENCE REVIEW,6(1),1-1. |
MLA | Song, Ruilin,et al."China's reform of the regulatory system for medical products and its impact".NATIONAL SCIENCE REVIEW 6.1(2019):1-1. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论